Where Science Meets Strategy...
We Innovate Solutions

BioMedical Insights is a premier provider of analytic and strategic consulting services to the life sciences industry.

BIO MEDICAL INSIGHTS

BioMedical Insights, Inc. is a boutique strategic and analytic life sciences consulting firm specializing in new product development and market access solutions. We are trusted partner in navigating the complex healthcare landscape.

Established in

0 +

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis.

Capabilities and Services

Lorem ipsum dolor sit amet, consectetur adipiscing elit.

Therapeutic Expertise

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet,

BioMedical Insights

BioMedical Insights, Inc., (BMI) is a boutique life sciences consulting firm specializing in new product development, strategy, and market access. Since our founding in 1996, we have been a trusted partner to hundreds of clients navigating the complex healthcare landscape.

BMI provides exceptionally high-quality strategic analyses and input into the most complicated questions and situations faced by the industry. We serve established and start-up biotechnology, pharmaceutical, diagnostic, and medical device manufacturers, as well as investors.

Our Research

Therapeutic Expertise

How We Work

Our Working Process

01

02

03

04

Capabilities and Services

BMI offers a portfolio of services to help its clients address virtually all aspects of new product evaluation, development, and launch, and lifecycle management.

Business and Corporate Development

BMI offers a full range of strategic and research services around partnerships, acquisitions, licensing agreements

Learn More

New Product Planning and Portfolio Strategy

BMI provides a full range of services to help you systematically identify, evaluate, and optimize new product opportunities

Learn More

Market Access

A BMI core competency, we provide strategic planning and critical research to ensure market access for products coming to market

Learn More

Market Research and Analysis

BMI conducts exceptionally high-quality market research and analysis and provides synthesized findings and recommendations

Learn More

Pricing

BMI is engaged in all aspects of pricing strategy, development, and implementation

Learn More

Marketing and Sales

BMI’s strategic guidance, tactical support, and industry expertise is tailored to the unique challenges

Learn More

Therapeutic Expertise

With decades of experience exclusively in the life sciences, BioMedical Insights has experience across all major & minor disease categories, with depth and breadth in oncology and rare diseases in particular

Learn More

Business and Corporate Development

BMI offers a full range of strategic and research services around partnerships, acquisitions, licensing agreements

Learn More

New Product Planning and Portfolio Strategy

BMI provides a full range of services to help you systematically identify, evaluate, and optimize new product opportunities

Learn More

Market Access

A BMI core competency, we provide strategic planning and critical research to ensure market access for products coming to market

Learn More

Market Research and Analysis

BMI conducts exceptionally high-quality market research and analysis and provides synthesized findings and recommendations

Learn More

Pricing

BMI is engaged in all aspects of pricing strategy, development, and implementation

Learn More

Marketing and Sales

BMI’s strategic guidance, tactical support, and industry expertise is tailored to the unique challenges

Learn More

Therapeutic Expertise

With decades of experience exclusively in the life sciences, BioMedical Insights has experience across all major & minor disease categories, with depth and breadth in oncology and rare diseases in particular

Learn More

Therapeutic Expertise

With decades of experience exclusively in the life sciences, BioMedical Insights has experience across all major & minor disease categories, with depth and breadth in oncology and rare diseases in particular

Learn More

Years in Business

0 +

Clients

0 +

Projects

0 +

Therapeutic Areas

0 +

Repeat Client Business

0 %+

Our Clients

BMI works with CEOs, Chief Commercial Officers, functional heads and line managers in Business Development, New Product Planning, Market Access, Marketing and Sales, Market Research and Analytics, and R&D.

BMI’s client base ranges from new start-ups to industry leaders, including engagements with most of the leading biopharmaceutical companies. We take pride that the majority of our business comes from repeat customers and client referrals or word of mouth.

“I have worked closely with BioMedical Insights on evaluating a dozen different buy-side opportunities - across multiple modalities, disease areas, and development stages. They have superb command of the scientific, medical, and commercial domains, and a unique ability to analyze highly complex situations with insight and clarity of thinking. They deliver the highest level of thoughtful advice that draws on decades of experience and true passion for their work. They are the best consulting boutique I have worked with.”

CBO Biotech

“BMI consistently delivers comprehensive and excellent work. Their team is responsive to our needs and timelines and always provides critical insights.”

CEO Biotech

“We have engaged BioMedical Insights many times over the past decade to help us assess reimbursement issues during our MedTech due diligence. Across a wide spectrum of therapeutic areas, it is notable to us that everything they told us would likely happen with regard to a reimbursement pathway and the timing of that pathway has occurred as they said it would and within the time frame they identified. They are a trusted partner for these evaluations.”

Managing Director Venture Capital Firm

“BioMedical Insights has been a longtime trusted partner to evaluate reimbursement and find paths for patient access to emerging therapies.”

VP, Global Health Economics & Reimbursement Device Manufacturer

“I have worked with BMI for over two decades, and there is a reason for that. Regardless of the type of project, therapeutic area, or my high expectations, they’ve never delivered anything but the highest quality product. They are a true partner and always my first choice.”

Executive Director, New Product Planning Biotech

“I have worked with BMI for over 20 years, always on pioneering new therapies, including disease categories struggling to experience a successful product and new categories lacking precedents or comparables for gauging market potential. I have relied on BMI’s rigor and judgment across these projects. While I tend to be optimistic, infatuated with my next new thing, they remain clear-eyed, analytical, and willing to challenge my position. And that is why I continue to work with them.”

President & CEO Biotech Start-Up

Our Clients

BMI works with CEOs, Chief Commercial Officers, functional heads and line managers in Business Development, New Product Planning, Market Access, Marketing and Sales, Market Research and Analytics, and R&D.

BMI’s client base ranges from new start-ups to industry leaders, including engagements with most of the leading biopharmaceutical companies. We take pride that the majority of our business comes from repeat customers and client referrals or word of mouth.

“BMI consistently delivers comprehensive and excellent work. Their team is responsive to our needs and timelines and always provides critical insights.”

“I have worked closely with BioMedical Insights on evaluating a dozen different buy-side opportunities - across multiple modalities, disease areas, and development stages. They have superb command of the scientific, medical, and commercial domains, and a unique ability to analyze highly complex situations with insight and clarity of thinking. They deliver the highest level of thoughtful advice that draws on decades of experience and true passion for their work. They are the best consulting boutique I have worked with.”

“We have engaged BioMedical Insights many times over the past decade to help us assess reimbursement issues during our MedTech due diligence. Across a wide spectrum of therapeutic areas, it is notable to us that everything they told us would likely happen with regard to a reimbursement pathway and the timing of that pathway has occurred as they said it would and within the time frame they identified. They are a trusted partner for these evaluations.”

“BioMedical Insights has been a longtime trusted partner to evaluate reimbursement and find paths for patient access to emerging therapies.”

“I have worked with BMI for over two decades, and there is a reason for that. Regardless of the type of project, therapeutic area, or my high expectations, they’ve never delivered anything but the highest quality product. They are a true partner and always my first choice.”

“I have worked with BMI for over 20 years, always on pioneering new therapies, including disease categories struggling to experience a successful product and new categories lacking precedents or comparables for gauging market potential. I have relied on BMI’s rigor and judgment across these projects. While I tend to be optimistic, infatuated with my next new thing, they remain clear-eyed, analytical, and willing to challenge my position. And that is why I continue to work with them.”

Previous

Next

Our Expert

Meet Our Leadership

Emily Clay

Lorem Ipsum

Mark Manson

Lorem Ipsum

Stella Claire

Lorem Ipsum

SUBSCRIBE & FOLLOW US

Subscribe & Get More Information

Elizabeth K. Brooks, Partner, San Francisco

Ms. Brooks has worked in market research and health care policy for 30 years. During this time, she has helped biotechnology, pharmaceutical, and medical device companies develop marketing, reimbursement, distribution, and overall launch strategies for their products. Ms. Brooks has analyzed markets for, and provided due diligence support on, hundreds of therapeutics. She is also expert at reimbursement issues, offering analysis, education, and tactical support to pharmaceutical and biotechnology concerns, as well as medical device companies. In addition, Ms. Brooks has developed a model for helping companies evaluate the need for pharmacoeconomic studies and has trained hundreds of staff on the appropriate use of outcomes research tools. Ms. Brooks holds a Masters of Business Administration and an Honors Bachelor of Arts degree in English, both from the University of Chicago. She also earned a Certificate from the University of Chicago Graduate Program on Health Administration and Policy.

Elizabeth K. Brooks, Partner, San Francisco

Ms. Brooks has worked in market research and health care policy for 30 years. During this time, she has helped biotechnology, pharmaceutical, and medical device companies develop marketing, reimbursement, distribution, and overall launch strategies for their products. Ms. Brooks has analyzed markets for, and provided due diligence support on, hundreds of therapeutics. She is also expert at reimbursement issues, offering analysis, education, and tactical support to pharmaceutical and biotechnology concerns, as well as medical device companies. In addition, Ms. Brooks has developed a model for helping companies evaluate the need for pharmacoeconomic studies and has trained hundreds of staff on the appropriate use of outcomes research tools. Ms. Brooks holds a Masters of Business Administration and an Honors Bachelor of Arts degree in English, both from the University of Chicago. She also earned a Certificate from the University of Chicago Graduate Program on Health Administration and Policy.

Paul C. Nagle, Partner, San Francisco

Mr. Nagle has advised medical product manufacturers on a wide range of strategic issues for over 30 years. He specializes in market assessments, payer and reimbursement strategy, and pricing and contracting strategy. With his thorough knowledge of payer policies, he has helped dozens of product manufacturers understand and penetrate managed care, Medicare, and Medicaid segments, as well as provider segments when they are de facto payers. He also frequently conducts due diligence for M&A and licensing opportunities for manufacturers and the investment community. Mr. Nagle performs pricing analyses and develops contracting strategies (including multiple product contracting) using a variety of methodologies. Mr. Nagle also has significant expertise in international market assessments. Mr. Nagle is frequently called upon by his clients to research, analyze and strategize about particularly unique and challenging manufacturer dilemmas and novel areas of interest. Mr. Nagle holds a Bachelor of Science in Business Administration from the Olin School at Washington University in St. Louis.

Paul C. Nagle, Partner, San Francisco

Paul C. Nagle for over 30 years, Mr. Nagle has advised medical product manufacturers on a wide range of strategic issues. He specializes in pricing strategy, payer and reimbursement strategy, and assessing markets and products for licensing and M&A due diligence. Mr. Nagle’s focus is most frequently on the US and Europe, but also includes Japan and Brazil. He frequently consults to the investment community for opportunities under consideration. Mr. Nagle performs pricing analyses and develops pricing and contracting strategies using a variety of methodologies. Mr. Nagle also has significant expertise in third-world market assessments. Mr. Nagle is frequently called upon by his clients to research, analyze and strategize about particularly unique and challenging manufacturer dilemmas and novel areas of interest. Additionally, Mr. Nagle has helped state Medicaid programs and private payers understand the impact of specialty products, and his analyses have impacted Medicare legislation. Mr. Nagle holds a Bachelor of Science in Business Administration from the Olin School at Washington University in St. Louis. Before co-founding BioMedical Insights, Mr. Nagle was at Health Technology Associates, which became part of Covance.

Christopher A. Nicita, Partner, San Francisco

Mr. Nicita specializes in market and technology assessment, new product planning, and pricing and reimbursement strategy. He has over 30 years of experience in health care market analysis and medical research. Mr. Nicita has helped identify and evaluate opportunities afforded by dozens of new products, technologies, and markets and has helped the firm’s clients develop and launch a number of innovative new therapies. He has worked with a range of companies, from industry leaders to start-ups, to make sound portfolio investment decisions and to optimize clinical development strategy. Mr. Nicita frequently consults to companies on prospective in-licensing and merger and acquisition candidates, and has provided due diligence services to a variety of health care investors. He has broad expertise in most therapeutic classes and disease areas including oncology, infectious diseases, immune-mediated and inflammatory diseases, endocrinologic diseases, ultra rare genetic diseases, and cardiovascular diseases, among others. Mr. Nicita holds a Masters of Business Administration and an Honors Bachelor of Science in Molecular Biology, both from the University of Michigan.

Christopher A. Nicita, Partner, San Francisco

Mr. Nicita specializes in market and technology assessment, new product planning, and pricing and reimbursement strategy. He has over 30 years of experience in health care market analysis and medical research. Mr. Nicita has helped identify and evaluate opportunities afforded by dozens of new products, technologies, and markets and has helped the firm’s clients develop and launch a number of innovative new therapies. He has worked with a range of companies, from industry leaders to start-ups, to make sound portfolio investment decisions and to optimize clinical development strategy. Mr. Nicita frequently consults to companies on prospective in-licensing and merger and acquisition candidates, and has provided due diligence services to a variety of health care investors. He has broad expertise in most therapeutic classes and disease areas including oncology, infectious diseases, immune-mediated and inflammatory diseases, endocrinologic diseases, ultra rare genetic diseases, and cardiovascular diseases, among others. Mr. Nicita holds a Masters of Business Administration and an Honors Bachelor of Science in Molecular Biology, both from the University of Michigan.

Andrew P. Kloek, Ph.D., Principal, Nashville

Dr. Kloek has worked in market research, reimbursement and technology assessment with BioMedical Insights since 2007. He holds a Bachelor’s degree in Genetics and Chemistry from Western Kentucky University and a Ph.D. in Genetics from Washington University in St. Louis. Prior to joining BioMedical Insights, he spent eight years with biotechnology start-up companies including three years working with Affymetrix-based micro-array technologies at Perlegen Sciences, a Mountain View, California-based company focused on pharmacogenomics and personalized medicine. He has co-authored 20 peer-reviewed scientific publications and 10 issued patents in the fields of genetics and biotechnology.

Andrew Kloek, Ph.D., Principal, Nashville

Dr. Kloek has worked in market research, reimbursement and technology assessment with BioMedical Insights since 2007. He holds a Bachelor’s degree in Genetics and Chemistry from Western Kentucky University and a Ph.D. in Genetics from Washington University in St. Louis. Prior to joining BioMedical Insights, he spent eight years with biotechnology start-up companies including three years working with Affymetrix-based micro-array technologies at Perlegen Sciences, a Mountain View, California-based company focused on pharmacogenomics and personalized medicine. He has co-authored 20 peer-reviewed scientific publications and 10 issued patents in the fields of genetics and biotechnology.

Jacqueline D. Koenig, Principal, Houston

Ms. Koenig has been with BioMedical Insights since 2004. She helps life sciences and medical device companies conduct due diligence, analyze market nuances, assess licensing and investment opportunities, prioritize clinical indications, and create market access strategies across numerous therapeutic categories. Prior to joining BioMedical Insights, Jacqui worked at the Kaiser Family Foundation developing national public education campaigns and conducting public opinion and provider surveys. She started her career at what is now Covance (formerly Health Technology Associates). Ms. Koenig holds a Bachelor of Arts degree in Economics from Vassar College and a Master of Science in Business degree from Johns Hopkins University.

Jacqueline Koenig, Principal, Houston

Ms. Koenig has been with BioMedical Insights since 2004. She helps life sciences and medical device companies conduct due diligence, analyze market nuances, assess licensing and investment opportunities, prioritize clinical indications, and create market access strategies across numerous therapeutic categories. Prior to joining BioMedical Insights, Jacqui worked at the Kaiser Family Foundation developing national public education campaigns and conducting public opinion and provider surveys. She started her career at what is now Covance (formerly Health Technology Associates). Ms. Koenig holds a Bachelor of Arts degree in Economics from Vassar College and a Master of Science in Business degree from Johns Hopkins University.